These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 19389856

  • 1. Urine podocyte mRNAs mark progression of renal disease.
    Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M, Chang JW, Wiggins JE, Lienczewski C, Kretzler M, Wiggins RC.
    J Am Soc Nephrol; 2009 May; 20(5):1041-52. PubMed ID: 19389856
    [Abstract] [Full Text] [Related]

  • 2. Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker.
    Fukuda A, Wickman LT, Venkatareddy MP, Wang SQ, Chowdhury MA, Wiggins JE, Shedden KA, Wiggins RC.
    Nephrol Dial Transplant; 2012 Nov; 27(11):4079-87. PubMed ID: 22863839
    [Abstract] [Full Text] [Related]

  • 3. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
    Fukuda A, Sato Y, Iwakiri T, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S.
    Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.
    Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, Shedden KA, Dysko RC, Wiggins JE, Wiggins RC.
    Kidney Int; 2012 Jan; 81(1):40-55. PubMed ID: 21937979
    [Abstract] [Full Text] [Related]

  • 5. Increasing urinary podocyte mRNA excretion and progressive podocyte loss in kidney contribute to the high risk of long-term renal disease caused by preterm birth.
    Ding F, Gao Q, Tian X, Mo J, Zheng J.
    Sci Rep; 2021 Oct 19; 11(1):20650. PubMed ID: 34667204
    [Abstract] [Full Text] [Related]

  • 6. Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies.
    Rodrigues PG, Bringhenti RN, do Nascimento JF, Joelsons G, dos Santos M, Pereira S, Veronese FV.
    Int J Clin Exp Pathol; 2014 Oct 19; 7(5):2185-98. PubMed ID: 24966927
    [Abstract] [Full Text] [Related]

  • 7. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
    Wang G, Lai FM, Lai KB, Chow KM, Kwan BC, Li KT, Szeto CC.
    Ren Fail; 2010 Jan 19; 32(3):372-9. PubMed ID: 20370455
    [Abstract] [Full Text] [Related]

  • 8. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
    dos Santos M, Bringhenti RN, Rodrigues PG, do Nascimento JF, Pereira SV, Zancan R, Monticielo OA, Gasparin AA, de Castro WP, Veronese FV.
    Int J Clin Exp Pathol; 2015 Jan 19; 8(5):4600-13. PubMed ID: 26191151
    [Abstract] [Full Text] [Related]

  • 9. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD, Poveda J, Sanz AB, Mezzano S, Carrasco S, Fernandez-Fernandez B, Burkly LC, Nair V, Kretzler M, Hodgin JB, Ruiz-Ortega M, Selgas R, Egido J, Ortiz A.
    Biochim Biophys Acta; 2013 Dec 19; 1832(12):2232-43. PubMed ID: 23999007
    [Abstract] [Full Text] [Related]

  • 10. Podocyte stress and detachment measured in urine are related to mean arterial pressure in healthy humans.
    Naik AS, Le D, Aqeel J, Wang SQ, Chowdhury M, Walters LM, Cibrik DM, Samaniego M, Wiggins RC.
    Kidney Int; 2020 Sep 19; 98(3):699-707. PubMed ID: 32739208
    [Abstract] [Full Text] [Related]

  • 11. Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease.
    Zeng L, Ng JK, Fung WW, Chan GC, Chow KM, Szeto CC.
    BMC Nephrol; 2024 Jan 24; 25(1):32. PubMed ID: 38267859
    [Abstract] [Full Text] [Related]

  • 12. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
    Lioudaki E, Stylianou KG, Petrakis I, Kokologiannakis G, Passam A, Mikhailidis DP, Daphnis EK, Ganotakis ES.
    Nephron; 2015 Jan 24; 131(1):34-42. PubMed ID: 26340089
    [Abstract] [Full Text] [Related]

  • 13. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases.
    Wickman L, Afshinnia F, Wang SQ, Yang Y, Wang F, Chowdhury M, Graham D, Hawkins J, Nishizono R, Tanzer M, Wiggins J, Escobar GA, Rovin B, Song P, Gipson D, Kershaw D, Wiggins RC.
    J Am Soc Nephrol; 2013 Dec 24; 24(12):2081-95. PubMed ID: 24052633
    [Abstract] [Full Text] [Related]

  • 14. Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome.
    Ding F, Wickman L, Wang SQ, Zhang Y, Wang F, Afshinnia F, Hodgin J, Ding J, Wiggins RC.
    Kidney Int; 2017 Dec 24; 92(6):1515-1525. PubMed ID: 28754557
    [Abstract] [Full Text] [Related]

  • 15. [Relationship between podocyte molecule's distribution and expression, foot process morphology and proteinuria].
    Guan N, Deng JH, Ding J, Zhang JJ, Yang JY.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr 24; 36(2):139-44. PubMed ID: 15100730
    [Abstract] [Full Text] [Related]

  • 16. Increased tubular proliferation as an adaptive response to glomerular albuminuria.
    Guo JK, Marlier A, Shi H, Shan A, Ardito TA, Du ZP, Kashgarian M, Krause DS, Biemesderfer D, Cantley LG.
    J Am Soc Nephrol; 2012 Mar 24; 23(3):429-37. PubMed ID: 22193389
    [Abstract] [Full Text] [Related]

  • 17. Effect of cholecalciferol supplementation on urine podocyte-associated messenger RNAs in patients with chronic kidney disease.
    Timm JR, Karohl C, Santos MD, Souza ML, Zancan R, Almeida Rd, Veronese FV.
    J Bras Nefrol; 2016 Jun 24; 38(2):173-82. PubMed ID: 27438972
    [Abstract] [Full Text] [Related]

  • 18. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
    Perez-Hernandez J, Olivares MD, Forner MJ, Chaves FJ, Cortes R, Redon J.
    Nephrol Dial Transplant; 2016 May 24; 31(5):780-9. PubMed ID: 26932688
    [Abstract] [Full Text] [Related]

  • 19. Urinary podocyte and TGF-β1 mRNA as markers for disease activity and progression in anti-glomerular basement membrane nephritis.
    Fukuda A, Minakawa A, Sato Y, Iwakiri T, Iwatsubo S, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S.
    Nephrol Dial Transplant; 2017 Nov 01; 32(11):1818-1830. PubMed ID: 28419296
    [Abstract] [Full Text] [Related]

  • 20. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M, Yotsueda R, Torisu K, Kawai Y, Hasegawa S, Tanaka S, Noguchi H, Masutani K, Kitazono T, Tsuruya K.
    Am J Physiol Renal Physiol; 2016 Feb 15; 310(4):F322-33. PubMed ID: 26632605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.